Literature DB >> 9069162

High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women.

P Ravn1, M Rix, H Andreassen, B Clemmesen, M Bidstrup, M Gunnes.   

Abstract

A group of 366 healthy, white postmenopausal women, aged 50-81 years, mean age 66 years, were selected from the screened population of Scandinavians who were part of a multicenter study of the efficacy of tiludronate, a new bisphosphonate, in established postmenopausal osteoporosis. Eighty-eight women had a lumbar spine bone mineral density (BMD) above 0.860 g/cm2, and 278 women had a BMD below 0.860 g/cm2. Spinal fracture was diagnosed from lateral spine X-ray studies and defined as at least 20% height reduction (wedge, compression, or endplate fracture) in at least one vertebra (T4-L4). Bone resorption was assessed by measurement of the urinary excretion of type I collagen degradation products by the CrossLaps enzyme-linked immunoassay (ELISA). Bone formation was assessed by ELISA measurement of the N-terminal-midfragment as well as the intact serum osteocalcin (OCN-MID), thus omitting the influence of the instability of osteocalcin caused by the labile 6 amino acid C-terminal sequence. The women were divided into groups with high or low bone turnover according to the concentrations of urinary Cross-Laps or OCN-MID. Women in the quartiles with the highest concentrations of CrossLaps [519 +/- 119 micrograms/mmol (SD)] or OCN-MID [44.6 +/- 7.5 ng/ml (SD)] had 10-16% lower spinal BMD compared with women in the lowest quartiles (CrossLaps 170 +/- 48 micrograms/mmol (SD), and OCN-MID [22.1 +/- 3.0 ng/ml (SD)] (P < 0.0004). The prevalences of spinal fracture were 25 to 29% in the lowest quartiles, whereas the prevalences in the highest quartiles were almost double-53-54% (P < 0.006). If the women were subgrouped according to spinal BMD and prevalence of spinal fracture, corresponding results were found. Women with a BMD less than 0.860 g/cm2, without or with spinal fracture (n = 136 and n = 142), had 36-43% higher concentration of Cross-Laps (P = 0.0001) and 11-15% higher concentration of OCN-MID (P < 0.02), as compared with women with a BMD above 0.860 g/cm2 and no spinal fracture (n = 84). In conclusion, the results indicate a strong association among high bone turnover, low bone mass, and prevalence of spinal fracture, which supports the theory that high bone turnover is a risk factor for spinal fracture and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9069162     DOI: 10.1007/s002239900225

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  10 in total

Review 1.  Fast and slow bone losers. Relevance to the management of osteoporosis.

Authors:  S Hough
Journal:  Drugs Aging       Date:  1998       Impact factor: 3.923

2.  Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women.

Authors:  Yin-Zhen Pi; Xian-Ping Wu; Shi-Ping Liu; Xiang-Hang Luo; Xing-Zhi Cao; Hui Xie; Er-Yuan Liao
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial.

Authors:  Michael F Holick; Joseph J Lamb; Robert H Lerman; Veera R Konda; Gary Darland; Deanna M Minich; Anuradha Desai; Tai C Chen; Melissa Austin; Jacob Kornberg; Jyh-Lurn Chang; Alex Hsi; Jeffrey S Bland; Matthew L Tripp
Journal:  J Bone Miner Metab       Date:  2009-12-19       Impact factor: 2.626

4.  Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects.

Authors:  Yoshiki Nishizawa; Masaaki Inaba; Mitsukazu Ishii; Hiroyuki Yamashita; Takami Miki; Hitoshi Goto; Sinsuke Yamada; Osamu Chaki; Kentaro Kurasawa; Yoshiko Mochizuki
Journal:  J Bone Miner Metab       Date:  2008-05-11       Impact factor: 2.626

5.  Osteocyte-derived insulin-like growth factor I is not essential for the bone repletion response in mice.

Authors:  Kin-Hing William Lau; David J Baylink; Matilda H-C Sheng
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

6.  Age-related bone turnover markers and osteoporotic risk in native Chinese women.

Authors:  Xi-Yu Wu; Hong-Li Li; Hui Xie; Xiang-Hang Luo; Yi-Qun Peng; Ling-Qing Yuan; Zhi-Feng Sheng; Ru-Chun Dai; Xian-Ping Wu; Er-Yuan Liao
Journal:  BMC Endocr Disord       Date:  2014-01-22       Impact factor: 2.763

7.  Effects of high phosphorus diet on bone metabolism-related gene expression in young and aged mice.

Authors:  Shinichi Katsumata; Hiroshi Matsuzaki; Rie Katsumata-Tsuboi; Mariko Uehara; Kazuharu Suzuki
Journal:  J Nutr Metab       Date:  2014-11-19

8.  Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients.

Authors:  Hui Guo; Chiyu Wang; Boren Jiang; Shaohong Ge; Jian Cai; Ying Zhou; Rong Ying; Kexi Zha; Ji Zhou; Ningjian Wang; Chunfang Zhu; Chenyu Cao; Liqin Zhang; Tao Gu; Yan Zhao; Yingli Lu; Zengmei An
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-25       Impact factor: 5.555

9.  Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.

Authors:  J Collette; O Bruyère; J M Kaufman; R Lorenc; D Felsenberg; T D Spector; M Diaz-Curiel; S Boonen; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

10.  A hospital based study of biochemical markers of bone turnovers & bone mineral density in north Indian women.

Authors:  Ashok Kumar; Salam Gyaneshwori Devi; Soniya Mittal; Deepak Kumar Shukla; Shashi Sharma
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.